Johnson & Johnson (NYSE:JNJ) Agrees To Pay $6.3 Million For Deceiving Buyers Of Infant’s Tylenol

Johnson & Johnson (NYSE:JNJ) has agreed to pay $6.3 million to the buyers of Infant’s Tylenol. According to the lawsuit, the company has deceived the buyers with inappropriate advertizing and collecting excessive amounts.

The packaging boasts the image of a mother and child

Infant’s Tylenol has an image of a woman holding a baby, indicating that it is uniquely formulated for the babies. However, the product contains an equal amount of liquid acetaminophen with the same concentration as that of Tylenol. According to the argument of plaintiffs, Johnson & Johnson collected an excessive amount by deceiving the consumers with the wrong advertisement when it comprises medicine in the same amount of Tylenol.

Who are eligible to make a claim?

The consumers, who purchased Infant’s Tylenol between October 2014 and January 6, 2020, can lodge a claim to receive a portion of the settlement amount of $6.3 million. It is necessary to submit a proof of purchase for 2 or 1 fl. Oz bottle to receive $2.15 compensation before April 13, 2020. You can still claim up to $15.05 for a maximum of seven bottles without any proof. The customers can submit a claim before the scheduled date online. Johnson & Johnson will modify the packaging of Infant’s Tylenol accordingly, educate the consumers, and communicate to the customers.

Does the pooled data study of talc give a buy signal?

The JAMA (Journal of the American Medical Association) has published the results of the pooled data study of the talc that goes back to 1989. According to the article published on January 7, 2020, the study is focused on a quarter of a million women to find whether the use of talc powder caused ovarian cancer when applied in the genital area. According to the results, it showed a slightly increased risk to develop ovarian cancer. However, it is not significant. Do these findings give a buy signal? No.

During an eleven year follow up study on one million women, who do not use the talc powder, reported cancer rate of 55% when compared to 61% in one million women, who used the talc powder. After adjusting for the status of the reproductive organs and the age, it showed an increase of 8% increased risk for women, who used talc powder in the genital area, to develop ovarian cancer.

Leave a comment

Your email address will not be published. Required fields are marked *